The following comes from a March 31 Catholic News Agency article:
The US Food and Drug Administration on Wednesday expanded its recommended use of the abortion drug mifepristone, drawing criticism from pro-life advocates who say it is harmful for women and their unborn babies, who may now be chemically aborted up to 10 weeks into pregnancy.
Mifepristone is combined with the drug misoprostol to induce an abortion. The FDA’s March 30 policy change will allow the drug to be used up to 10 weeks into pregnancy instead of seven.
“The FDA has bowed to pressure from drug companies and abortion advocates, but the ones who will feel the deplorable effects of this change will be the women sent home to endure a painful and shocking process by themselves and of course their babies,” Dr. Grazie Pozo Christie, a physician and advisory board member with The Catholic Association, said March 31.
Maureen Ferguson, senior policy advisor at The Catholic Association, also criticized the determination.
“Anyone who approves of the FDA’s decision to extend at-home medical abortions up to 10 weeks of pregnancy should consult WebMD’s description of the 10 week old baby a woman will encounter as the abortion proceeds,” she said.
That description reads: “Your baby is still small but looks and acts like a baby. Arms and legs are longer and can bend at the elbows and knees.”
Abortion providers and pro-abortion rights advocates welcomed the FDA decision.
Opponents of the drug cited the FDA’s summary of its reported adverse effects. Between September 2000 and April 2011, 14 women died from the drug, more than 600 were hospitalized, and 58 women had ectopic pregnancies because of it.